ANAPLASTIC LYMPHOMA KINASE-POSITIVE

Clinical trials for ANAPLASTIC LYMPHOMA KINASE-POSITIVE explained in plain language.

Never miss a new study

Get alerted when new ANAPLASTIC LYMPHOMA KINASE-POSITIVE trials appear

Sign up with your email to follow new studies for ANAPLASTIC LYMPHOMA KINASE-POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for lung cancer patients: experimental drug aims to outperform current standard

Disease control Recruiting now

This study tests whether a new drug called NVL-655 works better than the current standard treatment (alectinib) for people with advanced ALK-positive lung cancer who haven't had treatment before. About 450 participants will be randomly assigned to receive either the new drug or t…

Matched conditions: ANAPLASTIC LYMPHOMA KINASE-POSITIVE

Phase: PHASE3 • Sponsor: Nuvalent Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

ANAPLASTIC LYMPHOMA KINASE-POSITIVE

Get alerted when new ANAPLASTIC LYMPHOMA KINASE-POSITIVE trials appear

New hope for lung cancer patients: experimental drug aims to outperform current standard